At this time, posts about Dongwha Pharm are rapidly increasing on portals and securities communities. Today, foreigners have sold a net 4,000 shares of Dongwha Pharm, and institutions have sold a net 3,000 shares, according to provisional data. Dongwha Pharm is known as a manufacturer and seller of pharmaceuticals (such as Gas Hwal Myung Su and Fusidin).


As of 11:30 AM on the 11th, Dongwha Pharm's stock price is 26,700 KRW, up 2.89% from the previous day, with a trading volume of 2,863,335 shares, which is 132.4% of the 5-day average trading volume.


In addition to Dongwha Pharm, posts by investors are also rapidly increasing regarding Ecobio (038870), Daehwa Pharmaceutical (067080), and Daishin Balance No.6 SPAC (307750).



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing